The pharmaceutical landscape is rapidly changing as patents for some of the blockbuster drugs of the last decade near expiration and other players try to grab some of the remaining revenues before ge

It’s a small shot in the arm, but it could mean big money for pharmaceutical companies around the world. With flu season upon us and swine flu threatening to reach pandemic proportions, Big Pha

Christian Andreach isn’t betting on a strong rebound here in the US. But the 36-year-old professional stock picker is wagering on faster growth overseas, a view confirmed by the many C-suite ex

Editors Note: Welcome to Love It or Hate It, a regular dual-column feature that will capture the love-hate relationship America has with some of its biggest, most controversial companies. For past co

Last April, when newspaper journalist Nathalie Atkinson wrote about the marked similarities between a jacket from a small Canadian design group and one from an international mega-brand, a minor storm

As he travels the country, chatting with C-suite executives from a range of diverse industries, Joe Milano, the 37-year-old manager of the T. Rowe Price New America Growth Fund (PRWAX), hears a commo

Retail Report Is the US consumer regaining its confidence? In a story by Reuters, grocery store chain Kroger (KR) said shoppers are starting to buy national brands again, instead of cheaper generic b

Years of mismanagement, increased competition, and ill-conceived promotions have caught up to Blockbuster (BBI). On Tuesday, the company announced plans to close 810 to 960 underperforming locations

Editor's Note: This content was originally posted to the Buzz & Banter. It's being republished here for the benefit of the Minyanville community.With continuing speculation about a deal between G

Inquiring minds are reading the details of an interview in the Tuscaloosa News with Congressman Spencer Bachus. Please consider Bachus discusses Social Security, health care.  “Social S